- AugustBio invests $65 million in expanding its Nashville facility.
- The expansion will increase manufacturing capacity and create 180 new jobs in the Davidson county.
AugustBio is investing $65 million to expand its manufacturing facility in Nashville, Tennessee. This project aims to enhance the company’s capacity and capabilities in contract manufacturing. The new facility will include state-of-the-art equipment and additional space for production and development.
The expansion is scheduled to be completed by the end of 2025. This move is expected to create numerous jobs in the local area, contributing to economic growth.
“Tennessee is the right choice for us in building our company and establishing our headquarters and building our new facilities as we grow up. When we build that facility it is going to support the manufacture drug product using clinical trials that one day can become new life saving therapies that can benefit all of us and our families,” said CEO Jenn Adams.
“There is no city in America that touches more people in health services than middle Tennessee and national Tennessee,” said Former US Senator Bill Frist.
Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing. 
